Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Trends Immunol ; 38(3): 151-153, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28089218

RESUMEN

Natural killer (NK) cells are alerted to infected and transformed cells by local upregulation of ligands for the NK-activating receptor NKG2D. In a recent report, Greene et al. unveil a new mechanism that induces the expression of the NKG2D ligand retinoic acid early-inducible (RAE-1) in response to murine cytomegalovirus (MCMV) infection through inhibition of casein kinase 2 (CK2), an activator of the repressor histone deacetylase HDAC3.


Asunto(s)
Infecciones por Herpesviridae/inmunología , Histona Desacetilasas/inmunología , Células Asesinas Naturales/inmunología , Muromegalovirus/inmunología , Subfamilia K de Receptores Similares a Lectina de Células NK/metabolismo , Animales , Quinasa de la Caseína II/metabolismo , Citotoxicidad Inmunológica , Epigénesis Genética , Células HEK293 , Humanos , Inmunidad Innata , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Ratones , Subfamilia K de Receptores Similares a Lectina de Células NK/inmunología , Transducción de Señal , Factor de Transcripción Sp3/genética , Factor de Transcripción Sp3/metabolismo
2.
Circ Res ; 123(7): 905-924, 2018 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-30355076

RESUMEN

Model organisms have provided fundamental evidence that aging can be delayed and longevity extended. These findings gave rise to a new era in aging research aimed at elucidating the pathways and networks controlling this complex biological process. The identification of 9 hallmarks of aging has established a framework to evaluate the relative contribution of each hallmark and the interconnections among them. In this review, we revisit these hallmarks with the information obtained exclusively through the generation of genetically modified mouse models that have a significant impact on the aging process. We discuss within each hallmark those interventions that accelerate aging or that have been successful at increasing lifespan, with the final goal of identifying the most promising antiaging avenues based on the current knowledge provided by in vivo models.


Asunto(s)
Envejecimiento/genética , Núcleo Celular/genética , Mitocondrias/genética , Factores de Edad , Envejecimiento/metabolismo , Envejecimiento/patología , Animales , Comunicación Celular , Núcleo Celular/metabolismo , Núcleo Celular/patología , ADN Mitocondrial , Metabolismo Energético , Epigénesis Genética , Inestabilidad Genómica , Genotipo , Humanos , Longevidad/genética , Ratones Transgénicos , Mitocondrias/metabolismo , Mitocondrias/patología , Modelos Animales , Fenotipo , Proteostasis , Transducción de Señal , Células Madre/metabolismo , Células Madre/patología , Telómero/genética , Telómero/metabolismo , Acortamiento del Telómero
3.
Biochim Biophys Acta Mol Cell Res ; 1864(11 Pt A): 2015-2025, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28499917

RESUMEN

Proteases are a set of enzymes that have been involved in multiple biological processes throughout evolution. Among them, extracellular matrix (ECM) remodeling has emerged as one of the most relevant functions exerted by these proteins, being essential in the regulation of critical events such as embryonic development or tissue homeostasis. Hence, it is not surprising that dysregulation in any protease function that affects ECM homeostasis may contribute to the aging process. Matrix metalloproteinases (MMPs) are one of the most important families of proteases involved in the tight control of ECM remodeling over time. In this review, we will discuss how MMPs and other proteases alter ECM composition and mechanical properties in aging, thereby affecting stem cell niches and the development of senescent phenotypes. Finally, we will summarize recent findings that associate MMPs with the development of age-related diseases, such as neurodegenerative disorders.


Asunto(s)
Envejecimiento/metabolismo , Matriz Extracelular/enzimología , Metaloproteinasas de la Matriz/metabolismo , Enfermedades Neurodegenerativas/enzimología , Nicho de Células Madre , Células Madre/enzimología , Envejecimiento/patología , Animales , Matriz Extracelular/patología , Humanos , Enfermedades Neurodegenerativas/patología , Células Madre/patología
4.
Brain Behav Immun ; 62: 151-161, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28126501

RESUMEN

We show here that the intraplantar administration of CCL5 in mice produces hyperalgesia at low doses but activates compensatory antinociceptive mechanisms at doses slightly higher. Thus, the injection of 3-10ng of CCL5 evoked thermal hyperalgesia through the activation of CCR1 and CCR5 receptors, as demonstrated by the inhibitory effect exerted by the selective antagonists J113863 (0.01-0.1µg) and DAPTA (0.3-3µg), respectively. The prevention of this hyperalgesia by diclofenac (1-10µg), the inhibitors of COX-1 SC-560 (0.1-1µg) or COX-2 celecoxib (1-5µg), the TRPV1 antagonist capsazepine (0.03-0.3µg) or the TRPA1 antagonist HC030031 (10-50µg) demonstrates the involvement of prostaglandin synthesis and TRP sensitization in CCL5-evoked hyperalgesia. Doses of CCL5 higher than 17µg did not evoke hyperalgesia. However, this effect was restored by the administration of naloxone-methiodide (5µg), nor-binaltorphimine (10mg/kg) or an anti-dynorphin A antibody (0.62-2.5ng). The administration of 30ng of CCL5 also induced hyperalgesia in mice with reduced number of circulating white blood cells in response to cyclophosphamide or with selective neutrophil depletion induced by an anti-Ly6G antibody. In fact, the number of neutrophils present in paws treated with 30ng of CCL5 was greater than in paws receiving the administration of the hyperalgesic dose of 10ng. Finally, the expression of the endogenous opioid peptide dynorphin A was demonstrated by double immunofluorescence assays in these neutrophils attracted by CCL5. These results support previous data describing the hyperalgesic properties of CCL5 and constitute the first indication that a chemokine of the CC group can activate endogenous analgesic mechanisms.


Asunto(s)
Quimiocina CCL5 , Hiperalgesia/inducido químicamente , Receptores CCR1/metabolismo , Receptores CCR5/metabolismo , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Celecoxib/administración & dosificación , Celecoxib/uso terapéutico , Inhibidores de la Ciclooxigenasa 2/administración & dosificación , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Diclofenaco/administración & dosificación , Diclofenaco/uso terapéutico , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/metabolismo , Masculino , Ratones , Dimensión del Dolor , Umbral del Dolor/efectos de los fármacos
7.
J Biol Chem ; 288(20): 14647-14656, 2013 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-23548910

RESUMEN

Human MMP-1 is a matrix metalloproteinase repeatedly associated with many pathological conditions, including cancer. Thus, MMP1 overexpression is a poor prognosis marker in a variety of advanced cancers, including colorectal, breast, and lung carcinomas. Moreover, MMP-1 plays a key role in the metastatic behavior of melanoma, breast, and prostate cancer cells. However, functional and mechanistic studies on the relevance of MMP-1 in cancer have been hampered by the absence of an in vivo model. In this work, we have generated mice deficient in Mmp1a, the murine ortholog of human MMP1. Mmp1a(-/-) mice are viable and fertile and do not exhibit obvious abnormalities, which has facilitated studies of cancer susceptibility. These studies have shown a decreased susceptibility to develop lung carcinomas induced by chemical carcinogens in Mmp1a(-/-) mice. Histopathological analysis indicated that tumors generated in Mmp1a(-/-) mice are smaller than those of wild-type mice, consistently with the idea that the absence of Mmp-1a hampers tumor progression. Proteomic analysis revealed decreased levels of chitinase-3-like 3 and accumulation of the receptor for advanced glycation end-products and its ligand S100A8 in lung samples from Mmp1a(-/-) mice compared with those from wild-type. These findings suggest that Mmp-1a could play a role in tumor progression by modulating the polarization of a Th1/Th2 inflammatory response to chemical carcinogens. On the basis of these results, we propose that Mmp1a knock-out mice provide an excellent in vivo model for the functional analysis of human MMP-1 in both physiological and pathological conditions.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Inflamación/metabolismo , Neoplasias Pulmonares/metabolismo , Metaloproteinasa 1 de la Matriz/metabolismo , Animales , Carcinoma/metabolismo , Proliferación Celular , Progresión de la Enfermedad , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Metástasis de la Neoplasia , Péptido Hidrolasas/metabolismo , Pronóstico , Uretano
8.
Aging Cell ; 22(10): e13952, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-37565451

RESUMEN

Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disease caused by nuclear envelope alterations that lead to accelerated aging and premature death. Several studies have linked health and longevity to cell-extrinsic mechanisms, highlighting the relevance of circulating factors in the aging process as well as in age-related diseases. We performed a global plasma proteomic analysis in two preclinical progeroid models (LmnaG609G/G609G and Zmpste24-/- mice) using aptamer-based proteomic technology. Pathways related to the extracellular matrix, growth factor response and calcium ion binding were among the most enriched in the proteomic signature of progeroid samples compared to controls. Despite the global downregulation trend found in the plasma proteome of progeroid mice, several proteins associated with cardiovascular disease, the main cause of death in HGPS, were upregulated. We also developed a chronological age predictor using plasma proteome data from a cohort of healthy mice (aged 1-30 months), that reported an age acceleration when applied to progeroid mice, indicating that these mice exhibit an "old" plasma proteomic signature. Furthermore, when compared to naturally-aged mice, a great proportion of differentially expressed circulating proteins in progeroid mice were specific to premature aging, highlighting secretome-associated differences between physiological and accelerated aging. This is the first large-scale profiling of the plasma proteome in progeroid mice, which provides an extensive list of candidate circulating plasma proteins as potential biomarkers and/or therapeutic targets for further exploration and hypothesis generation in the context of both physiological and premature aging.


Asunto(s)
Envejecimiento Prematuro , Progeria , Humanos , Ratones , Animales , Progeria/metabolismo , Envejecimiento Prematuro/genética , Proteómica , Proteoma/metabolismo , Secretoma , Lamina Tipo A/genética , Lamina Tipo A/metabolismo
9.
Proc Natl Acad Sci U S A ; 106(38): 16451-6, 2009 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-19805319

RESUMEN

Peripheral interactions between nociceptive fibers and mast cells contribute to inflammatory pain, but little is known about mechanisms mediating neuro-immune communication. Here we show that metalloproteinase MT5-MMP (MMP-24) is an essential mediator of peripheral thermal nociception and inflammatory hyperalgesia. We report that MT5-MMP is expressed by CGRP-containing peptidergic nociceptors in dorsal root ganglia and that Mmp24-deficient mice display enhanced sensitivity to noxious thermal stimuli under basal conditions. Consistently, mutant peptidergic sensory neurons hyperinnervate the skin, a phenotype that correlates with changes in the regulated cleavage of the cell-cell adhesion molecule N-cadherin. In contrast to basal nociception, Mmp24(-/-) mice do not develop thermal hyperalgesia during inflammation, a phenotype that appears associated with alterations in N-cadherin-mediated cell-cell interactions between mast cells and sensory fibers. Collectively, our findings demonstrate an essential role of MT5-MMP in the development of dermal neuro-immune synapses and suggest that this metalloproteinase may be a target for pain control.


Asunto(s)
Ganglios Espinales/metabolismo , Hiperalgesia/fisiopatología , Metaloproteinasas de la Matriz Asociadas a la Membrana/metabolismo , Nociceptores/metabolismo , Animales , Western Blotting , Células COS , Cadherinas/metabolismo , Línea Celular Tumoral , Células Cultivadas , Chlorocebus aethiops , Femenino , Técnica del Anticuerpo Fluorescente , Ganglios Espinales/citología , Calor , Humanos , Hiperalgesia/genética , Hiperalgesia/metabolismo , Inflamación/genética , Inflamación/metabolismo , Inflamación/fisiopatología , Masculino , Metaloproteinasas de la Matriz Asociadas a la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mutación , Enfermedades del Sistema Nervioso Periférico/genética , Enfermedades del Sistema Nervioso Periférico/metabolismo , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Transfección
10.
Biochim Biophys Acta ; 1803(1): 3-19, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19631700

RESUMEN

Matrix metalloproteinases (MMPs) are a large family of zinc-endopeptidases which play important roles in multiple physiological and pathological processes. These enzymes are widely distributed in all kingdoms of life and have likely evolved from a single-domain protein which underwent successive rounds of duplication, gene fusion and exon shuffling events to generate the multidomain architecture and functional diversity currently exhibited by MMPs. Proper regulation of these enzymes is required to prevent their unwanted activity in a variety of disorders, including cancer, arthritis and cardiovascular diseases. Multiple hormones, cytokines and growth factors are able to induce MMP expression, although the tissue specificity of the diverse family members is mainly achieved by the combination of different transcriptional control mechanisms. The integration of multiple signaling pathways, coupled with the cooperation between several cis-regulatory elements found at the MMP promoters facilitates the strict spatiotemporal control of MMP transcriptional activity. Additionally, epigenetic mechanisms, such as DNA methylation or histone acetylation, may also contribute to MMP regulation. Likewise, post-transcriptional regulatory processes including mRNA stability, protein translational efficiency, and microRNA-based mechanisms have been recently described as modulators of MMP gene expression. Parallel studies have led to the identification of MMP polymorphisms and mutations causally implicated in the development of different genetic diseases. These genomic analyses have been further extended through the generation of animal models of gain- or loss-of-function for MMPs which have allowed the identification of novel functions for these enzymes and the establishment of causal relationships between MMP dysregulation and development of different human diseases. Further genomic studies of MMPs, including functional analysis of gene regulation and generation of novel animal models will help to answer the multiple questions still open in relation to a family of enzymes which strongly influence multiple events in life and disease.


Asunto(s)
Evolución Molecular , Regulación Enzimológica de la Expresión Génica , Metaloproteinasas de la Matriz/genética , Metaloproteinasas de la Matriz/metabolismo , Modelos Animales , Animales , Enfermedad , Epigénesis Genética , Metaloproteinasas de la Matriz/clasificación , Ratones
11.
Nature ; 437(7058): 564-8, 2005 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-16079796

RESUMEN

Zmpste24 (also called FACE-1) is a metalloproteinase involved in the maturation of lamin A (Lmna), an essential component of the nuclear envelope. Both Zmpste24- and Lmna-deficient mice exhibit profound nuclear architecture abnormalities and multiple histopathological defects that phenocopy an accelerated ageing process. Similarly, diverse human progeroid syndromes are caused by mutations in ZMPSTE24 or LMNA genes. To elucidate the molecular mechanisms underlying these devastating diseases, we have analysed the transcriptional alterations occurring in tissues from Zmpste24-deficient mice. We demonstrate that Zmpste24 deficiency elicits a stress signalling pathway that is evidenced by a marked upregulation of p53 target genes, and accompanied by a senescence phenotype at the cellular level and accelerated ageing at the organismal level. These phenotypes are largely rescued in Zmpste24-/-Lmna+/- mice and partially reversed in Zmpste24-/-p53-/- mice. These findings provide evidence for the existence of a checkpoint response activated by the nuclear abnormalities caused by prelamin A accumulation, and support the concept that hyperactivation of the tumour suppressor p53 may cause accelerated ageing.


Asunto(s)
Envejecimiento/fisiología , Proteínas de la Membrana/deficiencia , Metaloendopeptidasas/deficiencia , Transducción de Señal , Proteína p53 Supresora de Tumor/metabolismo , Envejecimiento/genética , Animales , Células Cultivadas , Eliminación de Gen , Heterocigoto , Lamina Tipo A/deficiencia , Lamina Tipo A/genética , Lamina Tipo A/metabolismo , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Metaloendopeptidasas/genética , Metaloendopeptidasas/metabolismo , Ratones , Ratones Noqueados , Fenotipo , Proteína p53 Supresora de Tumor/deficiencia , Proteína p53 Supresora de Tumor/genética
12.
Blood ; 112(6): 2539-45, 2008 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-18523150

RESUMEN

Proteolytic events at the cell surface are essential in the regulation of signal transduction pathways. During the past years, the family of type II transmembrane serine proteases (TTSPs) has acquired an increasing relevance because of their privileged localization at the cell surface, although our current understanding of the biologic function of most TTSPs is limited. Here we show that matriptase-2 (Tmprss6), a recently described member of the TTSP family, is an essential regulator of iron homeostasis. Thus, Tmprss6(-/-) mice display an overt phenotype of alopecia and a severe iron deficiency anemia. These hematologic alterations found in Tmprss6(-/-) mice are accompanied by a marked up-regulation of hepcidin, a negative regulator of iron export into plasma. Likewise, Tmprss6(-/-) mice have reduced ferroportin expression in the basolateral membrane of enterocytes and accumulate iron in these cells. Iron-dextran therapy rescues both alopecia and hematologic alterations of Tmprss6(-/-) mice, providing causal evidence that the anemic phenotype of these mutant mice results from the blockade of intestinal iron export into plasma after dietary absorption. On the basis of these findings, we conclude that matriptase-2 activity represents a novel and relevant step in hepcidin regulation and iron homeostasis.


Asunto(s)
Homeostasis , Hierro/metabolismo , Proteínas de la Membrana/fisiología , Serina Endopeptidasas/fisiología , Alopecia/etiología , Anemia Ferropénica/etiología , Animales , Péptidos Catiónicos Antimicrobianos/metabolismo , Hepcidinas , Ratones , Ratones Noqueados
13.
Haematologica ; 94(6): 840-9, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19377077

RESUMEN

Maintaining the body's levels of iron within precise boundaries is essential for normal physiological function. Alterations of these levels below or above the healthy limit lead to a systemic deficiency or overload in iron. The type-two transmembrane serine protease (TTSP), matriptase-2 (also known as TMPRSS6), is attracting significant amounts of interest due to its recently described role in iron homeostasis. The finding of this regulatory role for matriptase-2 was originally derived from the observation that mice deficient in this protease present with anemia due to elevated levels of hepcidin and impaired intestinal iron absorption. Further in vitro analysis has demonstrated that matriptase-2 functions to suppress bone morphogenetic protein stimulation of hepcidin transcription through cell surface proteolytic processing of the bone morphogenetic protein co-receptor hemojuvelin. Consistently, the anemic phenotype of matriptase-2 knockout mice is mirrored in humans with matripase-2 mutations. Currently, 14 patients with iron-refractory iron deficiency anemia (IRIDA) have been reported to harbor various genetic mutations that abrogate matriptase-2 proteolytic activity. In this review, after overviewing the membrane anchored serine proteases, in particular the TTSP family, we summarize the identification and characterization of matriptase-2 and describe its functional relevance in iron metabolism.


Asunto(s)
Homeostasis , Hierro/metabolismo , Proteínas de la Membrana/metabolismo , Serina Endopeptidasas/metabolismo , Anemia Ferropénica/genética , Anemia Ferropénica/metabolismo , Animales , Humanos , Proteínas de la Membrana/genética , Modelos Biológicos , Mutación , Serina Endopeptidasas/genética
14.
FASEB J ; 22(9): 3207-15, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18495757

RESUMEN

Nitric oxide (NO) plays a critical role in wound healing, in part by promoting angiogenesis. However, the precise repair pathways affected by NO are not well defined. We now show that NO regulates matrix metalloproteinase-13 (MMP-13) release during wound repair. We find that normally MMP-13 is kept inside endothelial cells by an association with caveolin-1. However, nitration of MMP-13 on tyrosine residue Y338 causes it to dissociate from caveolin-1 and be released from endothelial cells. We next explored the functional significance of MMP-13 nitration in vivo. Skin injury increases nitration of MMP-13 in mice. Skin wounds in inducible nitric oxide synthase knockout mice release less MMP-13 and heal more slowly than skin wounds in wild-type mice. Conversely, skin wounds in caveolin-1 knockout mice have increased NO production, increased MMP-13 nitration, and accelerated wound healing. Collectively, our data reveal a new pathway through which NO modulates wound repair: nitration of MMP-13 promotes its release from endothelial cells, where it accelerates angiogenesis and wound healing.


Asunto(s)
Metaloproteinasa 13 de la Matriz/metabolismo , Óxido Nítrico/farmacología , Cicatrización de Heridas/fisiología , Secuencia de Aminoácidos , Animales , Caveolina 1/deficiencia , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Óxido Nítrico Sintasa de Tipo II/fisiología , Tirosina/metabolismo
15.
Nat Med ; 25(3): 423-426, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30778239

RESUMEN

CRISPR/Cas9-based therapies hold considerable promise for the treatment of genetic diseases. Among these, Hutchinson-Gilford progeria syndrome, caused by a point mutation in the LMNA gene, stands out as a potential candidate. Here, we explore the efficacy of a CRISPR/Cas9-based approach that reverts several alterations in Hutchinson-Gilford progeria syndrome cells and mice by introducing frameshift mutations in the LMNA gene.


Asunto(s)
Sistemas CRISPR-Cas , Terapia Genética/métodos , Lamina Tipo A/genética , Progeria/terapia , Animales , Células HEK293 , Humanos , Lamina Tipo A/metabolismo , Ratones , Mutación Puntual , Progeria/genética
16.
Mol Neurobiol ; 56(3): 1578-1595, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29907903

RESUMEN

In the present study, we characterize the antinociceptive effects produced by the chemokine CCL4 in mice. The intraplantar administration of very low doses of CCL4 (0.1-3 pg) produced bilateral antinociception assessed by the unilateral hot-plate test (UHP) without evoking chemotactic responses at the injection site. Moreover, the subcutaneous administration of CCL4 (3-100 pg/kg) also yielded bilateral antinociception in the UHP and the paw pressure test and reduced the number of spinal neurons that express Fos protein in response to noxious stimulation. The implication of peripheral CCR5 but not CCR1 in CCL4-evoked antinociception was deduced from the inhibition produced by systemic but not intrathecal, administration of the CCR5 antagonist DAPTA, and the inefficacy of the CCR1 antagonist J113863. Besides, the inhibition observed after subcutaneous but not intrathecal administration of naloxone demonstrated the involvement of peripheral opioids and the efficacy of naltrindole but not cyprodime or nor-binaltorphimine supported the participation of δ-opioid receptors. In accordance, plasma levels of met-enkephalin, but not ß-endorphin, were augmented in response to CCL4. Likewise, CCL4-evoked antinociception was blocked by the administration of an anti-met-enk antibody. Leukocyte depletion experiments performed with cyclophosphamide, anti-Ly6G, or anti-CD3 antibodies indicated that the antinociceptive effect evoked by CCL4 depends on circulating T lymphocytes. Double immunofluorescence experiments showed a four times more frequent expression of met-enk in CD4+ than in CD8+ T lymphocytes. CCL4-induced antinociception almost disappeared upon CD4+, but not CD8+, lymphocyte depletion with selective antibodies, thus supporting that the release of met-enk from CD4+ lymphocytes underlies the opioid antinociceptive response evoked by CCL4.


Asunto(s)
Analgésicos/uso terapéutico , Linfocitos T CD4-Positivos/efectos de los fármacos , Quimiocina CCL4/uso terapéutico , Encefalina Metionina/metabolismo , Nocicepción/efectos de los fármacos , Dolor/tratamiento farmacológico , Analgésicos/farmacología , Animales , Linfocitos T CD4-Positivos/metabolismo , Quimiocina CCL4/farmacología , Ratones , Naloxona/farmacología , Naltrexona/análogos & derivados , Naltrexona/farmacología , Antagonistas de Narcóticos/farmacología , Dolor/metabolismo , Dimensión del Dolor
17.
Cancer Res ; 66(10): 5234-41, 2006 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-16707448

RESUMEN

Among matrix metalloproteinases (MMP), MMP-19 displays unique structural features and tissue distribution. In contrast to most MMPs, MMP-19 is expressed in normal human epidermis and down-regulated during malignant transformation and dedifferentiation. The contribution of MMP-19 during tumor angiogenesis is presently unknown. In an attempt to give new insights into MMP-19 in vivo functions, angiogenic response of mutant mice lacking MMP-19 was analyzed after transplantation of murine malignant PDVA keratinocytes and after injection of Matrigel supplemented with basic fibroblast growth factor. In situ hybridization and immunohistochemical analysis revealed that MMP-19 is produced by host mesenchymal cells but not by endothelial capillary cells or CD11b-positive inflammatory cells. Based on a new computer-assisted method of quantification, we provide evidence that host MMP-19 deficiency was associated with an increased early angiogenic response. In addition, increased tumor invasion was observed in MMP-19-/- mice. We conclude that, in contrast to most MMPs that promote tumor progression, MMP-19 is a negative regulator of early steps of tumor angiogenesis and invasion. These data highlight the requirement to understand the individual functions of each MMP to improve anticancer strategies.


Asunto(s)
Metaloendopeptidasas/deficiencia , Neoplasias Cutáneas/irrigación sanguínea , Animales , Colágeno , Combinación de Medicamentos , Femenino , Laminina , Masculino , Metaloproteinasas de la Matriz Secretadas , Metaloendopeptidasas/biosíntesis , Metaloendopeptidasas/genética , Metaloendopeptidasas/metabolismo , Ratones , Ratones Endogámicos C57BL , Invasividad Neoplásica , Neovascularización Patológica/enzimología , Neovascularización Patológica/patología , Proteoglicanos , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/patología , Células del Estroma/enzimología
18.
Methods Mol Biol ; 1731: 235-245, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29318558

RESUMEN

For decades, proteases have been associated with cancer progression due to the ability of some members of this large group of enzymes to degrade tumor cell surroundings, thereby facilitating cancer invasion and dissemination. However, the generation of mouse models deficient in proteases has revealed the existence of a great variety of functions among proteolytic enzymes in cancer biology, including important tumor-suppressive roles. Therefore, in this chapter, we describe methods to chemically induce different types of cancer (lung adenocarcinoma, hepatocellular carcinoma, oral and esophageal carcinoma, colorectal carcinoma, skin cancer, and fibrosarcoma) in genetically modified mouse models to efficiently evaluate the specific pro- or antitumoral function of proteases in cancer.


Asunto(s)
Carcinoma/genética , Fibrosarcoma/genética , Neoplasias Experimentales/genética , Neoplasias/genética , Péptido Hidrolasas/genética , Animales , Carcinogénesis/inducido químicamente , Carcinogénesis/genética , Carcinoma/inducido químicamente , Carcinoma/patología , Femenino , Fibrosarcoma/inducido químicamente , Fibrosarcoma/patología , Predisposición Genética a la Enfermedad , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Neoplasias/inducido químicamente , Neoplasias/patología , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/patología
19.
Nat Commun ; 9(1): 1350, 2018 04 10.
Artículo en Inglés | MEDLINE | ID: mdl-29636509

RESUMEN

Alterations in iron status have frequently been associated with obesity and other metabolic disorders. The hormone hepcidin stands out as a key regulator in the maintenance of iron homeostasis by controlling the main iron exporter, ferroportin. Here we demonstrate that the deficiency in the hepcidin repressor matriptase-2 (Tmprss6) protects from high-fat diet-induced obesity. Tmprss6 -/- mice show a significant decrease in body fat, improved glucose tolerance and insulin sensitivity, and are protected against hepatic steatosis. Moreover, these mice exhibit a significant increase in fat lipolysis, consistent with their dramatic reduction in adiposity. Rescue experiments that block hepcidin up-regulation and restore iron levels in Tmprss6-/- mice via anti-hemojuvelin (HJV) therapy, revert the obesity-resistant phenotype of Tmprss6-/- mice. Overall, this study describes a role for matritpase-2 and hepcidin in obesity and highlights the relevance of iron regulation in the control of adipose tissue function.


Asunto(s)
Tejido Adiposo/metabolismo , Hepcidinas/genética , Hierro/metabolismo , Proteínas de la Membrana/genética , Obesidad/genética , Serina Endopeptidasas/genética , Tejido Adiposo/patología , Animales , Anticuerpos Monoclonales/farmacología , Dieta Alta en Grasa/efectos adversos , Proteínas Ligadas a GPI , Regulación de la Expresión Génica , Proteína de la Hemocromatosis , Hepcidinas/metabolismo , Homeostasis , Metabolismo de los Lípidos , Masculino , Proteínas de la Membrana/antagonistas & inhibidores , Proteínas de la Membrana/deficiencia , Proteínas de la Membrana/metabolismo , Ratones , Ratones Noqueados , Obesidad/etiología , Obesidad/patología , Obesidad/prevención & control , Serina Endopeptidasas/deficiencia , Transducción de Señal
20.
Mol Cell Biol ; 24(12): 5304-13, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15169894

RESUMEN

Matrix metalloproteinase 19 (MMP-19) is a member of the MMP family of endopeptidases that, in contrast to most MMPs, is widely expressed in human tissues under normal quiescent conditions. MMP-19 has been found to be associated with ovulation and angiogenic processes and is deregulated in diverse pathological conditions such as rheumatoid arthritis and cancer. To gain further insights into the in vivo functions of this protease, we have generated mutant mice deficient in Mmp19. These mice are viable and fertile and do not display any obvious abnormalities. However, Mmp19-null mice develop a diet-induced obesity due to adipocyte hypertrophy and exhibit decreased susceptibility to skin tumors induced by chemical carcinogens. Based on these results, we suggest that this enzyme plays an in vivo role in some of the tissue remodeling events associated with adipogenesis, as well as in pathological processes such as tumor progression.


Asunto(s)
Metaloendopeptidasas/deficiencia , Obesidad/etiología , Neoplasias Cutáneas/prevención & control , Adipocitos/enzimología , Adipocitos/patología , Animales , Secuencia de Bases , Carcinógenos/toxicidad , Tamaño de la Célula , ADN Complementario/genética , Dieta , Femenino , Marcación de Gen , Humanos , Técnicas In Vitro , Masculino , Metaloproteinasas de la Matriz Secretadas , Metaloendopeptidasas/genética , Metaloendopeptidasas/fisiología , Metilcolantreno/toxicidad , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neovascularización Fisiológica , Obesidad/enzimología , Obesidad/genética , Obesidad/patología , Fenotipo , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA